Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

This stack requires monitoring: 0 interaction(s) need attention. No critical conflicts, but bloodwork and regular check-ins recommended.
Elevated gonads load from Halotestin, Testosterone. Monitor this organ system closely.

Cumulative Organ Load

Gonads
elevated
Heart
moderate
Liver
moderate
Pancreas
low

Shared Safety Flags

2x 2 androgenic compounds (Halotestin, Testosterone). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds share the carcinogenic-risk safety flag (Halotestin, Testosterone). Monitor accordingly.
2x 2 hepatotoxic compounds (Halotestin, Testosterone). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 HPTA-suppressive compounds (Halotestin, Testosterone). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (Halotestin, Testosterone). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Halotestin, Testosterone). Monitor accordingly.
++
Halotestin + Testosterone
Synergistic

A testosterone base is considered essential when using halotestin. Fluoxymesterone will rapidly suppress endogenous testosterone production, and it provides no estrogenic activity. Without exogenous testosterone, users will experience symptoms of low estrogen (joint pain, low libido, poor mood) and hypogonadism. Typical combination: TRT-dose testosterone (100-200 mg/week) alongside halotestin 10-20 mg/day for the final 2-4 weeks of a cycle.

Researched 95% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.